Static Chart Cartesian Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
26.43 ^USD	+0.34%		+24.85%	+27.79%

Apr. 23	Leerink Partners Starts Cartesian Therapeutics With Outperform Rating, $39 Price Target	MT
Mar. 14	Cartesian Therapeutics, Inc Receives Notice from Audentes Therapeutics, Inc of Astellas? Termination of the License and Development Agreement	CI

Duration

Period